Pilot Study of TENS for Ocular Pain

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 3, 2022

Primary Completion Date

November 30, 2024

Study Completion Date

November 30, 2024

Conditions
Eye Pain
Interventions
DEVICE

Active Cefaly Dual (R)

Transcutaneous electrical nerve stimulation (TENS) device with electrode placement at the forehead. A biphasic rectangular wave will be delivered for a maximum of 20 minutes at a maximum amplitude of 16mA. Participant may halt amplitude before it reaches maximum amplitude. The device has previously been cleared by the FDA for use in migraine patients.

DEVICE

Sham Cefaly Dual (R)

Transcutaneous electrical nerve stimulation (TENS) device with electrode placement at the forehead. A 1Hz wave will be delivered for 20 minutes at 1mA.

Trial Locations (1)

33125

Miami VA Healthcare System, Miami, FL, Miami

All Listed Sponsors
lead

VA Office of Research and Development

FED